Skip to content

Functional magnetic resonance imaging-guided precise positioning rTMS for the treatment of refractory irritable bowel syndrome

Precise positioning of rTMS for treatment of refractory irritable bowel syndrome

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049392
Enrollment
Unknown
Registered
2021-08-01
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

irritable bowel syndrome

Interventions

DLPFC-rTMS group:rRTMS stimulated the left DLPFC
M1-rTMS group:rTMS stimulated the left M1
sham-rTMS group:rTMS sham stimulation

Sponsors

Affiliated Hospital of Hangzhou Normal University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: 1.Meet the Roman IV diagnostic criteria of IBS; 2.Refractory IBS refers to those who are still ineffective or have little effect after 12 weeks of conventional treatment (piveronium bromide or gastrointestinal motility drugs + dietary adjustment + lifestyle adjustment, and spasmolysis to regulate intestinal flora); 3.Patients have stopped taking relevant therapeutic drugs for more than 2 weeks; 4.Visual analog scale (VAS) score >5; 5.Aged 18 to 59 years; 6.Cognitive ability to agree to treatment, understand research instructions and questionnaires.

Exclusion criteria

Exclusion criteria: 1.Patients with contraindications of rTMS and MRI; 2.Mental illness; 3.Pregnant women; 4.Signs of serious illness and/or indications of hospitalization, including hemodynamic instability, infection, acute myocardial infarction and cerebral infarction.

Design outcomes

Primary

MeasureTime frame
visceral hypersensitivity;pain degree;Severity of irritable bowel syndrome;Degree of depression and anxiety;life quality;Imaging indicators of brain function;

Countries

China

Contacts

Public ContactLi Jie

Affiliated Hospital of Hangzhou Normal University

jie_sweethz@163.com+86 15988858667

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026